Medicare

Deck of “Trump Cards” Collapses Pharma Deal

After a roller coaster ride entailing months of on again-off again negotiations with US president Donald Trump over drug prices, the country’s pharmaceutical industry is licking its wounds and gearing up for a fight.

Former Lilly President to Head US Health Department

High Drug Prices Said “Infecting” Generics

Americans Blame Drugmakers for High Prices

Drugmakers Face More Scrutiny of Discordant U.S. Prices

Brakes on U.S. Health Spending Go Beyond the Recession

U.S. Sues Novartis, Alleging Kickbacks to Pharmacies

Generics Brought Down Common Drug Prices in 2012

Obama Medicare Rebate Plan Could Hurt Drug Companies

Pharma Group Calls for Broader US Market Approach in Medicare

Healthcare Reform in the U.S.: What Supreme Court Ruling Could Mean

Patent Cliff To Intensify in the U.S. in 2011